How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) issued its quarterly earnings data on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The medical equipment provider earned $1.67 million during the quarter, compared to the consensus estimate of $3 million.

What other stocks do shareholders of Corindus Vascular Robotics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN) , Advanced Micro Devices (AMD) , Micron Technology (MU) , Alibaba Group (BABA) , Helios and Matheson Analytics (HMNY) , NVIDIA (NVDA) , TherapeuticsMD (TXMD) , Ambarella (AMBA) and Exelixis (EXEL) .

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEAMERICAN:CVRS

Corindus Vascular Robotics (CVRS) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free CVRS Stock Alerts

$4.27

0.00 (0.00%)

(As of 11/27/2019)

Compare

Today's Range: $4.27
▼
$4.27
50-Day Range: N/A
52-Week Range: $0.78
▼
$4.40

Volume: N/A
Average Volume: 1.99 million shs
Market Capitalization: $891.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Corindus Vascular Robotics alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Corindus Vascular Robotics Stock (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

CVRS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CVRS Stock News Headlines

March 22, 2024 | thestreet.com

Corindus Vascular Robotics, Inc.

February 9, 2024 | benzinga.com

HealthCor Partners Fund II, L.P.'s Net Worth

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

May 28, 2023 | forbes.com

Robotics, AI And Cognitive Computing Are Changing Organizations Even Faster Than We Thought

April 21, 2023 | marketwatch.com

2023-2030 Robotic Vascular Catheter System Market Size with [94 Pages] includes Growth Rate Analysis | New Report by Absolute Reports

March 2, 2023 | techcrunch.com

Robotics & AI

January 29, 2023 | finance.yahoo.com

Ganymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 M

January 17, 2023 | finance.yahoo.com

The Worldwide Industrial Robotics Industry is Expected to Reach $43.9 Billion in 2027

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

January 5, 2023 | finance.yahoo.com

Monopoly Dreams(TM) and Novelte Robotics Join Forces to Pamper Visitors with Interactive Information & Tour Guide Service - RoboButler

October 9, 2022 | finance.yahoo.com

Robotics as a Service (RaaS) Market to record USD 1.23 Bn incremental growth -- Driven by changes in the global labor force

September 12, 2022 | apnews.com

Corindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular System

August 30, 2022 | investing.com

CVRS_old Historical Data

April 13, 2022 | finance.yahoo.com

Corindus Announces New Office Opening in Newton to Support Growth

January 5, 2022 | investing.com

Corindus Vascular Robotics Inc (CVRS_old)

November 11, 2021 | apnews.com

IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

See More Headlines

Receive CVRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Corindus Vascular Robotics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/07/2018
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: N/A
Current Symbol: NYSEAMERICAN:CVRS
Previous Symbol: NYSEMKT:CVRS
CUSIP: N/A
CIK: N/A
Web: www.corindus.com
Phone: +1-508-6533335
Fax: N/A
Employees: 90
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 208,685,000
Free Float: N/A
Market Cap: $891.08 million
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Mark J. Toland (Age 49)
CEO, Pres & Director
Mr. David W. Long (Age 49)
CFO, Sr. VP, Sec. & Treasurer
Mr. Douglas Teany (Age 47)
Chief Operating Officer
Ms. Nora Dutta
Sr. VP of HR
Dr. J. Aaron Grantham
Chief Medical Officer of Cardiovascular

Key Competitors

View All Competitors

CVRS Stock Analysis - Frequently Asked Questions

How were Corindus Vascular Robotics' earnings last quarter?: Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) issued its quarterly earnings data on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The medical equipment provider earned $1.67 million during the quarter, compared to the consensus estimate of $3 million.
What other stocks do shareholders of Corindus Vascular Robotics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY), NVIDIA (NVDA), TherapeuticsMD (TXMD), Ambarella (AMBA) and Exelixis (EXEL).
How do I buy shares of Corindus Vascular Robotics?: Shares of CVRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:CVRS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Corindus Vascular Robotics (CVRS) Stock Price, News & Analysis

About Corindus Vascular Robotics Stock (NYSEAMERICAN:CVRS)

CVRS Stock Price History

CVRS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CVRS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info